Perfuze Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
46
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$24.4M
- Investors
-
10
Perfuze General Information
Description
Developer of a thrombectomy device platform designed to simplify and accelerate clot removal during acute ischemic stroke treatment. The company offers a large-lumen aspiration catheter architecture with preserved lumen integrity and streamlined device design, enabling neurointerventional clinicians to achieve effective clot removal with fewer procedural steps and reliable vessel access.
Contact Information
Website
www.perfuze.comCorporate Office
- Unit 6, Galway Business Park
- Dangan
- Galway H91 W7CP
- Ireland
Corporate Office
- Unit 6, Galway Business Park
- Dangan
- Galway H91 W7CP
- Ireland
Perfuze Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 01-Oct-2024 | $24.4M | Completed | Clinical Trials - General | ||
| 4. Early Stage VC (Series A) | 09-Feb-2022 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Dec-2020 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jul-2019 | $2.82M | $3.5M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 29-Jan-2019 | $3.5M | $3.5M | Completed | Pre-Clinical Trials |
Perfuze Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Participating Preferred | ||||||||
| Series A Participating Preferred | ||||||||
| Series A Participating Preferred | 11,352 | $0.001111 | $240.15 | $240.15 | 1x | $240.15 | 5.56% | |
| SSPP | 18,619 | $0.001111 | $182.94 | $182.94 | 1x | $182.94 | 9.12% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Perfuze Comparisons
Industry
Financing
Details
Perfuze Competitors (2)
One of Perfuze’s 2 competitors is Route 92, a Venture Capital-Backed company based in West Jordan, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Route 92 | Venture Capital-Backed | West Jordan, UT | ||||
| Imperative Care | Venture Capital-Backed | Campbell, CA |
Perfuze Patents
Perfuze Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12239797-B2 | Corrugated catheters | Active | 18-Jun-2019 | ||
| US-20250319280-A1 | Corrugated catheters | Pending | 18-Jun-2019 | ||
| EP-3986519-A1 | Improvements in corrugated catheters | Active | 18-Jun-2019 | ||
| EP-3986519-B1 | Improvements in corrugated catheters | Active | 18-Jun-2019 | ||
| EP-4613215-A2 | Improvements in corrugated catheters | Pending | 18-Jun-2019 | A61M25/0053 |
Perfuze Signals
Perfuze Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EQT | PE/Buyout | Minority | ||
| V-Ventures | Corporation | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| Seroba Life Sciences | Venture Capital | Minority | ||
| SV Health Investors | PE/Buyout | Minority |
Perfuze FAQs
-
When was Perfuze founded?
Perfuze was founded in 2018.
-
Where is Perfuze headquartered?
Perfuze is headquartered in Galway, Ireland.
-
What is the size of Perfuze?
Perfuze has 46 total employees.
-
What industry is Perfuze in?
Perfuze’s primary industry is Surgical Devices.
-
Is Perfuze a private or public company?
Perfuze is a Private company.
-
What is Perfuze’s current revenue?
The current revenue for Perfuze is .
-
How much funding has Perfuze raised over time?
Perfuze has raised $53.4M.
-
Who are Perfuze’s investors?
EQT, V-Ventures, EQT Life Sciences, Seroba Life Sciences, and SV Health Investors are 5 of 10 investors who have invested in Perfuze.
-
Who are Perfuze’s competitors?
Route 92 and Imperative Care are competitors of Perfuze.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process